The North America dominates the Chronic Lymphocytic Leukemia Therapeutics Market due to its well established healthcare system, high healthcare expenditure, and strong focus on cancer research and innovation. The country has witnessed increasing adoption of targeted therapies, monoclonal antibodies, and combination treatment regimens that improve survival rates and patient outcomes. The Chronic...